Please login to the form below

Not currently logged in
Email:
Password:

infertility

This page shows the latest infertility news and features for those working in and with pharma, biotech and healthcare.

Organon buys Forendo in $1bn deal

Organon buys Forendo in $1bn deal

to one in ten women of reproductive age that causes abdominal pain and is associated with infertility. ... Forendo also has a preclinical programme targeting polycystic ovarian syndrome (PCOS), a common condition associated with metabolic disorders,

Latest news

More from news
Approximately 1 fully matching, plus 37 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    of infertility, miscarriages and developmental disorders, and could eventually lead to therapeutic applications of stem cells.

  • Interview: Michel Pettigrew, Ferring Interview: Michel Pettigrew, Ferring

    As an example of controlled entrepreneurship he cites an Argentinian infertility deal that, in order to meet the specific needs of that market, saw Ferring's general manager bolster its offering

  • The right direction

    Published: 05 Dec 2010. Client:RESOLVE: The National Infertility Association. Agency:Spectrum. Campaign:The Destination: Family. ... In 2009, Spectrum was tasked with developing a public service announcement and targeted media outreach campaign on the

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...